Literature DB >> 1698772

Site-directed mutagenesis of Moloney murine leukemia virus reverse transcriptase. Demonstration of lysine 103 in the nucleotide binding site.

A Basu1, S Basu, M J Modak.   

Abstract

Lys103 and Lys421 of Moloney murine leukemia virus reverse transcriptase have been implicated in the dNTP binding function as judged by their reactivity to a substrate binding site-directed reagent, pyridoxal 5'-phosphate (Basu, A., Nanduri, V. B., Gerard, G. F., and Modak, M. J. (1988) J. Biol. Chem. 263, 1648-1653). To assess the true catalytic importance of the individual lysine residues in Moloney murine leukemia virus reverse transcriptase, we mutated Lys103 and Lys421 to leucine and alanine, respectively. Analysis of the mutant enzymes revealed that mutation at the 103 position had a drastic effect on the DNA polymerase activity whereas the 421 mutation had no effect. Both mutants exhibited normal RNase H activity as well as the ability to bind to RNA or DNA templates as judged by UV-mediated cross-linking of the enzyme to the template primers. The enzyme with mutation at codon 421 (Lys----Ala) exhibited properties that were indistinguishable from the wild type with respect to its mode of catalysis, i.e. preference of template primer and divalent metal ion, RNA- or DNA-dependent DNA polymerase activity, RNase H activity, and the processive mode of DNA synthesis. These observations suggest that only Lys103 and not Lys421 is the catalytically important residue that is involved in the binding of substrate dNTP in Moloney murine leukemia virus reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698772

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Mechanism of polyoxometalate-mediated inactivation of DNA polymerases: an analysis with HIV-1 reverse transcriptase indicates specificity for the DNA-binding cleft.

Authors:  S G Sarafianos; U Kortz; M T Pope; M J Modak
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

2.  Structure-based moloney murine leukemia virus reverse transcriptase mutants with altered intracellular direct-repeat deletion frequencies.

Authors:  J K Pfeiffer; M M Georgiadis; A Telesnitsky
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Mutation of lysine residues in the nucleotide binding segments of the poliovirus RNA-dependent RNA polymerase.

Authors:  O C Richards; S Baker; E Ehrenfeld
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Sulphydryl groups in the template-primer-binding domain of murine leukaemia virus reverse transcriptase. Identification and functional analysis of cysteine-90.

Authors:  S Basu; A Basu; M J Modak
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

Review 5.  M-MuLV reverse transcriptase: Selected properties and improved mutants.

Authors:  Igor P Oscorbin; Maxim L Filipenko
Journal:  Comput Struct Biotechnol J       Date:  2021-11-22       Impact factor: 7.271

6.  Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid.

Authors:  Elzbieta Nowak; Wojciech Potrzebowski; Petr V Konarev; Jason W Rausch; Marion K Bona; Dmitri I Svergun; Janusz M Bujnicki; Stuart F J Le Grice; Marcin Nowotny
Journal:  Nucleic Acids Res       Date:  2013-02-04       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.